Marker Therapeutics, Inc.
SEC Filing List
MRKR CIK: 0001094038
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 10-Q | Quarterly report pursuant to Section 13 ... | Marker Therapeutics, Inc. | Toppan Merrill/FA | 05/15/2026 | |
| 8-K | Current report filing | Marker Therapeutics, Inc. | Toppan Merrill/FA | 05/04/2026 | |
| ARS | Annual report to security holders | Marker Therapeutics, Inc. | Toppan Merrill/FA | 03/20/2026 | |
| DEF 14A | Definitive proxy statements | Marker Therapeutics, Inc. | Toppan Merrill/FA | 03/20/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Marker Therapeutics, Inc. | Toppan Merrill/FA | 03/20/2026 | |
| 8-K | Current report filing | Marker Therapeutics, Inc. | Toppan Merrill/FA | 03/19/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Marker Therapeutics, Inc. | Toppan Merrill/FA | 03/18/2026 | |
| PRE 14A | Preliminary proxy statement not related ... | Marker Therapeutics, Inc. | Toppan Merrill/FA | 03/10/2026 | |
| 8-K | Current report filing | Marker Therapeutics, Inc. | Toppan Merrill/FA | 02/09/2026 | |
| 4 | Statement of changes in beneficial owner... | Elms Steve | Toppan Merrill/FA | 11/19/2025 | |
| No record found. | |||||
| Load More | |||||
